Cannabis Report
Home > Boards > US Listed > Biotechs >

Alimera Sciences (ALIM)

ALIM RSS Feed
Add ALIM Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/5/2018 7:13:18 AM - Followers: 36 - Board type: Free - Posts Today: 0




Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
The Company focuses on diseases affecting the back of the eye, or retina. The Company's commercial product is ILUVIEN, which has been developed to
treat diabetic macular edema (DME). ILUVIEN has received marketing authorization in the United States, Austria, Belgium, the Czech Republic, Denmark,
Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and the United Kingdom.
In the United States, ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and
did not have a rise in intraocular pressure (IOP). In the EU countries, it is indicated for the treatment of vision impairment associated with DME.


ALIM http://seekingalpha.com/article/3967057-2-small-biotech-stocks-poised-substantial-upside ;

https://www.google.com/finance?q=alim&ei=i_AYV-CbFsrHigKv8oioDA


Fox Business News interview with the CEO accounted for the news. 
04-21-2016
http://bit.ly/23LQSlZ 

FDA approves new diabetes implant 
Apr. 21, 2016 - 3:25 - Alimera Sciences CEO Dan Myers on a new diabetes implant that treats macular degeneration.
 http://www.alimerasciences.com/
http://www.alimerasciences.com/

Retinal Vein Occlusion (RVO)

ILUVIEN® Patent Notices

Please see the following table for U.S. Patents covering ILUVIEN®. The absence of a U.S. Patent number as associated with ILUVIEN does not constitute a waiver of our patent, trademark, or other intellectual property rights concerning that product.

PRODUCT

PATENT NO.

ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg

U.S. 6,217,895

U.S. 6,375,972

U.S. 6,548,078

U.S. 8,252,307

U.S. 8,574,659

U.S. 8,871,241

 
http://www.alimerasciences.com/wp-content/uploads/2016/02/Prescribing-Information.pdf

http://finance.yahoo.com/q/ks?s=ALIM+Key+Statistics

Alimera Sciences, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the back of the eye or retina. The company is developing ILUVIEN, an intravitreal insert in phase-3 clinical trials for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN insert designed to be inserted into the patient's eye to release a daily dose of fluocinolone acetonide over an anticipated period of 24 to 36 months. The company also conducts phase-2 clinical trials on ILUVIEN for the treatment of the dry form of age-related macular degeneration (AMD), the wet form of AMD, and retinal vein occlusion. In addition, it conducts testing on two classes of nicotinamide adenine dinucleotide phosphate oxidase inhibitors. Further, the company develops ILUVIEN inserter, a custom insertion system for ILUVIEN. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia.
 
Alimera Sciences Inc. is based out of Alpharetta, GA and has some 132 employees.

Officers and directors

 
Richard S. Eiswirth Jr.   President, Chief Financial Officer
C. Daniel Myers   Chief Executive Officer, Director
Kenneth E Green Ph.D.   Senior Vice President, Chief Scientific Officer
David R Holland   Senior Vice President - Sales and Marketing
Philip Ashman   Senior Vice President, European Managing Director
David Burke   Vice President
Mark J. Brooks   Independent Director
Brian K. Halak Ph.D.   Independent Director
James R. Largent   Independent Director
Peter J. Pizzo III   Independent Director
 

Stonegate Capital Partners Initiates Coverage on Alimera Sciences

http://www.barchart.com/headlines/story/1467222/stonegate-capital-partners-initiates-coverage-on-alimera-sciences
ACCESSWIRE via CMTX - Wed Apr 27, 8:02AM CDT


 


Alimera Sciences Reports Record Fourth Quarter and Full Year 2015 Financial Results
Mar 2, 2016



 
Cannabis Report
ALIM
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALIM News: Alimera Sciences Announces Nine Clinical Presentations and a Sponsored Symposium at 18th EURETINA Congress 09/17/2018 05:32:00 PM
ALIM News: Alimera Sciences Announces Three Podium Presentations for ILUVIENĀ® to be Presented at 2018 Retina Society's Annual Meeting 09/13/2018 04:30:00 PM
ALIM News: Current Report Filing (8-k) 09/05/2018 12:09:01 PM
ALIM News: Current Report Filing (8-k) 09/05/2018 06:07:59 AM
ALIM News: Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock 09/04/2018 05:43:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#919   News out! Timber! CarlCarlMcB 09/05/18 07:13:18 AM
#918   .0001 CarlCarlMcB 08/03/18 12:38:01 PM
#917   TIMBER!!! CarlCarlMcB 05/23/18 03:24:38 PM
#916   .09 coming ! CarlCarlMcB 05/14/18 12:49:19 PM
#915   Falling knife !!!.0001 CarlCarlMcB 05/08/18 03:01:42 PM
#914   .80 going ! CarlCarlMcB 05/08/18 08:02:15 AM
#913   degrees ????? mick 04/20/18 11:23:03 AM
#912   Timber !!! .85 today!!! CarlCarlMcB 04/20/18 07:23:17 AM
#911   Alimera Sciences, In (ALIM) mick 04/18/18 11:27:56 AM
#910   Timber CarlCarlMcB 04/16/18 10:54:14 AM
#909   http://www.stockscores.com/charts/charts/?ticker=ALIM mick 04/07/18 01:07:38 PM
#908   Alimera Sciences, In (ALIM) mick 03/14/18 08:41:39 AM
#907   What happens,when the nucleus leaves the Company?!!! CarlCarlMcB 03/14/18 06:37:04 AM
#906   http://www.barchart.com/detailedquote/stocks/ALIM mick 02/28/18 12:57:53 PM
#905   Shorts going to take this down ! .01 CarlCarlMcB 02/07/18 09:25:53 AM
#904   Hit the lights ! CarlCarlMcB 01/29/18 04:15:15 PM
#903   Timber .01 CarlCarlMcB 01/29/18 04:09:18 PM
#902   http://www.barchart.com/opinions/stocks/ALIM mick 01/23/18 08:23:21 PM
#901   Alimera Sciences, In (ALIM) mick 01/23/18 08:23:13 PM
#900   Don't worry . .65 CarlCarlMcB 12/29/17 04:35:13 AM
#899   Trying to get some @ 1.30, let's see Corpsman2012 12/14/17 01:23:44 PM
#898   http://www.barchart.com/opinions/stocks/ALIM mick 12/01/17 06:23:35 AM
#897   thank you/ Alimera Sciences, In (ALIM) mick 11/29/17 01:13:35 PM
#896   $$$$$ CarlCarlMcB 11/28/17 06:31:20 AM
#895   https://www.stockscores.com/charts/charts/?ticker=ALIM mick 10/08/17 02:13:00 PM
#894   Alimera Sciences, In (ALIM) mick 08/31/17 03:41:35 PM
#893   .0001 CarlCarlMcB 07/13/17 06:14:11 PM
#892   Alimera Sciences, In (ALIM) mick 07/09/17 11:45:15 AM
#891   ALIM News: Quarterly Report (10-q) 05/11/2017 09:13:51 AM mick 05/24/17 07:34:57 AM
#890   Alimera Sciences, In (ALIM) mick 05/24/17 07:34:50 AM
#889   $ALIM mick 05/13/17 12:12:07 PM
#888   I listened to the CC this morning.E Europe is bbhuey 05/09/17 07:02:04 PM
#887   The mouse ran up the clock. UserBob 05/02/17 08:38:32 AM
#886   Alimera Sciences, In (ALIM) mick 04/21/17 08:54:46 AM
#885   .12 CarlCarlMcB 04/21/17 05:06:42 AM
#884   interesting stuff/ $ALIM mick 04/19/17 04:42:17 PM
#883   Tick tock (.) CarlCarlMcB 04/19/17 03:09:01 PM
#882   Alimera Sciences, In (ALIM) mick 04/08/17 01:19:26 PM
#881   ALIM News: Statement of Changes in Beneficial Ownership mick 03/22/17 06:09:56 PM
#880   Alimera Sciences, In (ALIM) mick 03/22/17 06:09:46 PM
#879   .0001 CarlCarlMcB 03/22/17 04:47:22 PM
#878   Yep. Come on .50 CarlCarlMcB 03/21/17 07:14:26 PM
#877   If so, I'll be buying! UserBob 03/21/17 11:22:43 AM
#876   I might be right, .50 CarlCarlMcB 03/21/17 07:22:04 AM
#875   ALIM Long! UserBob 03/16/17 09:55:40 PM
#874   I was hoping for .50 CarlCarlMcB 03/16/17 06:44:49 PM
#873   Yep. $$$$$ Go Big !!! CarlCarlMcB 03/16/17 06:42:49 PM
#872   Carl, Hitting $2.00 tomorrow wine maker 03/16/17 06:19:04 PM
#871   Hehehehe rnoutlaw21 03/16/17 03:02:50 PM
#870   Haha keep raising your pt. Stock up 20% rnoutlaw21 03/14/17 12:18:56 PM
PostSubject